Global Signal Transduction Inhibitors Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

November 2018 | 117 pages | ID: G20E42B173DEN
GlobalInfoResearch

Abstracts

Signal transduction inhibitors are drugs that may prevent the ability of cancer cells to multiply quickly and invade other tissues.

Scope of the Report:

Growing need for effective cancer diagnostics and innovative therapies for cancer treatment are expected to be the major factors driving the signal transduction inhibitors market.

The global Signal Transduction Inhibitors market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Signal Transduction Inhibitors.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Signal Transduction Inhibitors market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Signal Transduction Inhibitors market by product type and applications/end industries.

Market Segment by Companies, this report covers

• Bristol-Myers Squibb
• Roche
• AstraZeneca
• GSK
• Novartis
• Amgen
• Pfizer

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Dasatinib
• Erlotinib
• Gefitinib
• Imatinib
• Lapatinib
• Nilotinib
• Pazopanib
• Sorafenib
• Sunitinib

Market Segment by Applications, can be divided into

• Hospital Pharmacies
• Retail Pharmacies

Contents

1 SIGNAL TRANSDUCTION INHIBITORS MARKET OVERVIEW

1.1 Product Overview and Scope of Signal Transduction Inhibitors
1.2 Classification of Signal Transduction Inhibitors by Types
  1.2.1 Global Signal Transduction Inhibitors Revenue Comparison by Types (2017-2023)
  1.2.2 Global Signal Transduction Inhibitors Revenue Market Share by Types in 2017
  1.2.3 Dasatinib
  1.2.4 Erlotinib
  1.2.5 Gefitinib
  1.2.6 Imatinib
  1.2.7 Lapatinib
  1.2.8 Nilotinib
  1.2.9 Pazopanib
  1.2.10 Sorafenib
  1.2.11 Sunitinib
1.3 Global Signal Transduction Inhibitors Market by Application
  1.3.1 Global Signal Transduction Inhibitors Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospital Pharmacies
  1.3.3 Retail Pharmacies
1.4 Global Signal Transduction Inhibitors Market by Regions
  1.4.1 Global Signal Transduction Inhibitors Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Signal Transduction Inhibitors Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Signal Transduction Inhibitors Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Signal Transduction Inhibitors Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Signal Transduction Inhibitors Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Signal Transduction Inhibitors Status and Prospect (2013-2023)
1.5 Global Market Size of Signal Transduction Inhibitors (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Bristol-Myers Squibb
  2.1.1 Business Overview
  2.1.2 Signal Transduction Inhibitors Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Bristol-Myers Squibb Signal Transduction Inhibitors Revenue, Gross Margin and Market Share (2016-2017)
2.2 Roche
  2.2.1 Business Overview
  2.2.2 Signal Transduction Inhibitors Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Roche Signal Transduction Inhibitors Revenue, Gross Margin and Market Share (2016-2017)
2.3 AstraZeneca
  2.3.1 Business Overview
  2.3.2 Signal Transduction Inhibitors Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 AstraZeneca Signal Transduction Inhibitors Revenue, Gross Margin and Market Share (2016-2017)
2.4 GSK
  2.4.1 Business Overview
  2.4.2 Signal Transduction Inhibitors Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 GSK Signal Transduction Inhibitors Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novartis
  2.5.1 Business Overview
  2.5.2 Signal Transduction Inhibitors Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Novartis Signal Transduction Inhibitors Revenue, Gross Margin and Market Share (2016-2017)
2.6 Amgen
  2.6.1 Business Overview
  2.6.2 Signal Transduction Inhibitors Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Amgen Signal Transduction Inhibitors Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
  2.7.1 Business Overview
  2.7.2 Signal Transduction Inhibitors Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Pfizer Signal Transduction Inhibitors Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL SIGNAL TRANSDUCTION INHIBITORS MARKET COMPETITION, BY PLAYERS

3.1 Global Signal Transduction Inhibitors Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Signal Transduction Inhibitors Players Market Share
  3.2.2 Top 10 Signal Transduction Inhibitors Players Market Share
3.3 Market Competition Trend

4 GLOBAL SIGNAL TRANSDUCTION INHIBITORS MARKET SIZE BY REGIONS

4.1 Global Signal Transduction Inhibitors Revenue and Market Share by Regions
4.2 North America Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
4.3 Europe Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
4.5 South America Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA SIGNAL TRANSDUCTION INHIBITORS REVENUE BY COUNTRIES

5.1 North America Signal Transduction Inhibitors Revenue by Countries (2013-2018)
5.2 USA Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
5.3 Canada Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
5.4 Mexico Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)

6 EUROPE SIGNAL TRANSDUCTION INHIBITORS REVENUE BY COUNTRIES

6.1 Europe Signal Transduction Inhibitors Revenue by Countries (2013-2018)
6.2 Germany Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
6.3 UK Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
6.4 France Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
6.5 Russia Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
6.6 Italy Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC SIGNAL TRANSDUCTION INHIBITORS REVENUE BY COUNTRIES

7.1 Asia-Pacific Signal Transduction Inhibitors Revenue by Countries (2013-2018)
7.2 China Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
7.3 Japan Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
7.4 Korea Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
7.5 India Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA SIGNAL TRANSDUCTION INHIBITORS REVENUE BY COUNTRIES

8.1 South America Signal Transduction Inhibitors Revenue by Countries (2013-2018)
8.2 Brazil Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
8.3 Argentina Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
8.4 Colombia Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE SIGNAL TRANSDUCTION INHIBITORS BY COUNTRIES

9.1 Middle East and Africa Signal Transduction Inhibitors Revenue by Countries (2013-2018)
9.2 Saudi Arabia Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
9.3 UAE Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
9.4 Egypt Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
9.5 Nigeria Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
9.6 South Africa Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)

10 GLOBAL SIGNAL TRANSDUCTION INHIBITORS MARKET SEGMENT BY TYPE

10.1 Global Signal Transduction Inhibitors Revenue and Market Share by Type (2013-2018)
10.2 Global Signal Transduction Inhibitors Market Forecast by Type (2018-2023)
10.3 Dasatinib Revenue Growth Rate (2013-2023)
10.4 Erlotinib Revenue Growth Rate (2013-2023)
10.5 Gefitinib Revenue Growth Rate (2013-2023)
10.6 Imatinib Revenue Growth Rate (2013-2023)
10.7 Lapatinib Revenue Growth Rate (2013-2023)
10.8 Nilotinib Revenue Growth Rate (2013-2023)
10.9 Pazopanib Revenue Growth Rate (2013-2023)
10.10 Sorafenib Revenue Growth Rate (2013-2023)
10.11 Sunitinib Revenue Growth Rate (2013-2023)

11 GLOBAL SIGNAL TRANSDUCTION INHIBITORS MARKET SEGMENT BY APPLICATION

11.1 Global Signal Transduction Inhibitors Revenue Market Share by Application (2013-2018)
11.2 Signal Transduction Inhibitors Market Forecast by Application (2018-2023)
11.3 Hospital Pharmacies Revenue Growth (2013-2018)
11.4 Retail Pharmacies Revenue Growth (2013-2018)

12 GLOBAL SIGNAL TRANSDUCTION INHIBITORS MARKET SIZE FORECAST (2018-2023)

12.1 Global Signal Transduction Inhibitors Market Size Forecast (2018-2023)
12.2 Global Signal Transduction Inhibitors Market Forecast by Regions (2018-2023)
12.3 North America Signal Transduction Inhibitors Revenue Market Forecast (2018-2023)
12.4 Europe Signal Transduction Inhibitors Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Signal Transduction Inhibitors Revenue Market Forecast (2018-2023)
12.6 South America Signal Transduction Inhibitors Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Signal Transduction Inhibitors Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Signal Transduction Inhibitors Picture
Table Product Specifications of Signal Transduction Inhibitors
Table Global Signal Transduction Inhibitors and Revenue (Million USD) Market Split by Product Type
Figure Global Signal Transduction Inhibitors Revenue Market Share by Types in 2017
Figure Dasatinib Picture
Figure Erlotinib Picture
Figure Gefitinib Picture
Figure Imatinib Picture
Figure Lapatinib Picture
Figure Nilotinib Picture
Figure Pazopanib Picture
Figure Sorafenib Picture
Figure Sunitinib Picture
Table Global Signal Transduction Inhibitors Revenue (Million USD) by Application (2013-2023)
Figure Signal Transduction Inhibitors Revenue Market Share by Applications in 2017
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Table Global Market Signal Transduction Inhibitors Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Signal Transduction Inhibitors Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Signal Transduction Inhibitors Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Signal Transduction Inhibitors Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Signal Transduction Inhibitors Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Signal Transduction Inhibitors Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Signal Transduction Inhibitors Revenue (Million USD) and Growth Rate (2013-2023)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Signal Transduction Inhibitors Type and Applications
Table Bristol-Myers Squibb Signal Transduction Inhibitors Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Signal Transduction Inhibitors Type and Applications
Table Roche Signal Transduction Inhibitors Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Signal Transduction Inhibitors Type and Applications
Table AstraZeneca Signal Transduction Inhibitors Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Signal Transduction Inhibitors Type and Applications
Table GSK Signal Transduction Inhibitors Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Signal Transduction Inhibitors Type and Applications
Table Novartis Signal Transduction Inhibitors Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Signal Transduction Inhibitors Type and Applications
Table Amgen Signal Transduction Inhibitors Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Signal Transduction Inhibitors Type and Applications
Table Pfizer Signal Transduction Inhibitors Revenue, Gross Margin and Market Share (2016-2017)
Table Global Signal Transduction Inhibitors Revenue (Million USD) by Players (2013-2018)
Table Global Signal Transduction Inhibitors Revenue Share by Players (2013-2018)
Figure Global Signal Transduction Inhibitors Revenue Share by Players in 2016
Figure Global Signal Transduction Inhibitors Revenue Share by Players in 2017
Figure Global Top 5 Players Signal Transduction Inhibitors Revenue Market Share in 2017
Figure Global Top 10 Players Signal Transduction Inhibitors Revenue Market Share in 2017
Figure Global Signal Transduction Inhibitors Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Signal Transduction Inhibitors Revenue (Million USD) by Regions (2013-2018)
Table Global Signal Transduction Inhibitors Revenue Market Share by Regions (2013-2018)
Figure Global Signal Transduction Inhibitors Revenue Market Share by Regions (2013-2018)
Figure Global Signal Transduction Inhibitors Revenue Market Share by Regions in 2017
Figure North America Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
Figure Europe Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
Figure South America Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
Table North America Signal Transduction Inhibitors Revenue by Countries (2013-2018)
Table North America Signal Transduction Inhibitors Revenue Market Share by Countries (2013-2018)
Figure North America Signal Transduction Inhibitors Revenue Market Share by Countries (2013-2018)
Figure North America Signal Transduction Inhibitors Revenue Market Share by Countries in 2017
Figure USA Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
Figure Canada Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
Figure Mexico Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
Table Europe Signal Transduction Inhibitors Revenue (Million USD) by Countries (2013-2018)
Figure Europe Signal Transduction Inhibitors Revenue Market Share by Countries (2013-2018)
Figure Europe Signal Transduction Inhibitors Revenue Market Share by Countries in 2017
Figure Germany Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
Figure UK Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
Figure France Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
Figure Russia Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
Figure Italy Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Signal Transduction Inhibitors Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Signal Transduction Inhibitors Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Signal Transduction Inhibitors Revenue Market Share by Countries in 2017
Figure China Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
Figure Japan Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
Figure Korea Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
Figure India Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
Table South America Signal Transduction Inhibitors Revenue by Countries (2013-2018)
Table South America Signal Transduction Inhibitors Revenue Market Share by Countries (2013-2018)
Figure South America Signal Transduction Inhibitors Revenue Market Share by Countries (2013-2018)
Figure South America Signal Transduction Inhibitors Revenue Market Share by Countries in 2017
Figure Brazil Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
Figure Argentina Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
Figure Colombia Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Signal Transduction Inhibitors Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Signal Transduction Inhibitors Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Signal Transduction Inhibitors Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Signal Transduction Inhibitors Revenue Market Share by Countries in 2017
Figure Saudi Arabia Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
Figure UAE Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
Figure Egypt Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
Figure Nigeria Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
Figure South Africa Signal Transduction Inhibitors Revenue and Growth Rate (2013-2018)
Table Global Signal Transduction Inhibitors Revenue (Million USD) by Type (2013-2018)
Table Global Signal Transduction Inhibitors Revenue Share by Type (2013-2018)
Figure Global Signal Transduction Inhibitors Revenue Share by Type (2013-2018)
Figure Global Signal Transduction Inhibitors Revenue Share by Type in 2017
Table Global Signal Transduction Inhibitors Revenue Forecast by Type (2018-2023)
Figure Global Signal Transduction Inhibitors Market Share Forecast by Type (2018-2023)
Figure Global Dasatinib Revenue Growth Rate (2013-2018)
Figure Global Erlotinib Revenue Growth Rate (2013-2018)
Figure Global Gefitinib Revenue Growth Rate (2013-2018)
Figure Global Imatinib Revenue Growth Rate (2013-2018)
Figure Global Lapatinib Revenue Growth Rate (2013-2018)
Figure Global Nilotinib Revenue Growth Rate (2013-2018)
Figure Global Pazopanib Revenue Growth Rate (2013-2018)
Figure Global Sorafenib Revenue Growth Rate (2013-2018)
Figure Global Sunitinib Revenue Growth Rate (2013-2018)
Table Global Signal Transduction Inhibitors Revenue by Application (2013-2018)
Table Global Signal Transduction Inhibitors Revenue Share by Application (2013-2018)
Figure Global Signal Transduction Inhibitors Revenue Share by Application (2013-2018)
Figure Global Signal Transduction Inhibitors Revenue Share by Application in 2017
Table Global Signal Transduction Inhibitors Revenue Forecast by Application (2018-2023)
Figure Global Signal Transduction Inhibitors Market Share Forecast by Application (2018-2023)
Figure Global Hospital Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Retail Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Signal Transduction Inhibitors Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Signal Transduction Inhibitors Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Signal Transduction Inhibitors Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Signal Transduction Inhibitors Revenue Market Forecast (2018-2023)
Figure Europe Signal Transduction Inhibitors Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Signal Transduction Inhibitors Revenue Market Forecast (2018-2023)
Figure South America Signal Transduction Inhibitors Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Signal Transduction Inhibitors Revenue Market Forecast (2018-2023)